IP Library Granted Patent US 10,426,870
Granted Patent B2
US 10,426,870 · App. 14/593,555 · Granted Oct 1, 2019

Biomaterials for enhanced implant-host integration

Inventors: Christopher S. Chen (Princeton, NJ); Jan D. Baranski (Philadelphia, PA); Ritika Chaturvedi (Philadelphia, PA); Michael T. Yang (West Windsor, NJ); Kelly Stevens (Seattle, WA); Sangeeta Bhatia (Lexington, MA)
Assignees: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA; The Massachusetts Institute of Technology
A61L27/50A61K35/44A61L27/225A61L27/24A61L27/3604A61L27/3804A61L27/3808A61L27/3834A61L27/3839A61L27/3886A61L27/40A61L27/507A61L2430/20A61L2430/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,426,870
App. No.
14/593,555
Granted
Oct 1, 2019
Kind
B2
Abstract

The present disclosure provides patterned biomaterials having organized cords and extracellular matrix embedded in a 3D scaffold. According, the present disclosure is provides compositions and applications for patterned biomaterials. Pre-patterning of these biomaterials can lead to enhanced integration of these materials into host organisms, providing a strategy for enhancing the viability of engineered tissues by promoting vascularization.

Claims (24)

1. A method of treating a subject for ischemia, comprising:

(1) providing a patterned biomaterial comprising: at least one cord, formed by embedding cells in a naturally-derived or synthetic scaffolding with a pre-specified architecture and spatially organizing the cells within the scaffolding, wherein the at least one cord comprises endothelial cells; and

(2) implanting the patterned biomaterial into a tissue of the subject, wherein the patterned biomaterial is configured to promote the vascularization of the patterned biomaterial and the tissue of the subject, wherein the structure of the patterned biomaterial has a pre-specified architecture that acts as a template and spatial guidance for the subject's vasculature, such that the subject's vasculature invades and integrates at least partially within the at least one cord.

2. The method of claim 1 , wherein the tissue of the subject is ischemic tissue.

3. The method of claim 1 , wherein the vascularization increases perfusion of the surrounding tissue.

4. The method of claim 1 , wherein the ischemia is cardiac ischemia, limb ischemia, intestinal ischemia, or liver ischemia.

5. The method of claim 1 , wherein the patterned biomaterial further comprises an extracellular matrix or other physically solid scaffold at least partially encapsulating the at least one cord.

6. The method of claim 5 , wherein the extracellular matrix scaffold comprises fibrin.

7. The method of claim 5 , wherein the extracellular matrix scaffold further comprises one or more cell types.

8. The method of claim 7 , wherein the one or more cell types comprises one or more cell types selected from the group consisting of: hepatocytes; endothelial cells; and mesenchymal stem cells.

9. The method of claim 7 , wherein the one or more cell types comprises endothelial cells.

10. The method of claim 1 , wherein the naturally-derived or synthetic scaffolding comprises collagen.

11. The method of claim 1 , wherein the tissue is liver tissue or cardiac tissue.

12. The method of claim 1 , wherein the at least one cord is branched.

13. The method of claim 1 , wherein the at least one cord comprises a plurality of cords.

14. The method of claim 13 , wherein the plurality of cords are formed in a parallel arrangement within the naturally-derived or synthetic scaffolding.

15. The method of claim 13 , wherein the plurality of cords are formed in a nonparallel arrangement within the naturally-derived or synthetic scaffolding.

16. The method of claim 1 , wherein the at least one cord is cylindrical, Y-shaped, or T-shaped.

17. The method of claim 1 , wherein the at least one cord is solid or hollow in cross-section.

18. The method of claim 1 , wherein the biomaterial further comprises at least one cluster of cells comprising one or more cell types.

19. The method of claim 18 , wherein the one or more cell types comprises one or more cell types selected from the group consisting of: hepatocytes, endothelial cells and mesenchymal stem cells.

20. A method of treating a subject for ischemia, comprising:

(1) providing a patterned biomaterial comprising: at least one cord, formed by embedding cells in a naturally-derived or synthetic scaffolding with a pre-specified architecture and spatially organizing the cells within the scaffolding, wherein the cells embedded in the naturally-derived or synthetic scaffolding consists of endothelial cells; and

(2) implanting the patterned biomaterial into a tissue of the subject, wherein the patterned biomaterial is configured to promote the vascularization of the patterned biomaterial and the tissue of the subject, wherein the structure of the patterned biomaterial has a pre-specified architecture that acts as a template and spatial guidance for the subject's vasculature, such that the subject's vasculature invades and integrates at least partially within the at least one cord.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2019
From: CHEN, CHRISTOPHER S.; BARANSKI, JAN D.; CHATURVEDI, RITIKA; YANG, MICHAEL T.
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 049988/0806 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2019
From: STEVENS, KELLY; BHATIA, SANGEETA
To: THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 049989/0056 →
CONFIRMATORY LICENSE Recorded Aug 4, 2015
From: UNIVERSITY OF PENNSYLVANIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036259/0129 →
Continuity (3)
Continuation PCTUS2013049933 · Jul 10, 2013
Provisional Application 61670100 · Jul 10, 2012
Related Publication 20150125507A1 · May 7, 2015
Cited By (1)
US 12,642,890